In addition, GCK, which is a kinase specific to glucose, is involved in the module of cohort 2, and it is significantly upregulated in the NAFLD patients compared with the normal subjects (Data S2). This evidence concerns the gene GCK and metabolic dysfunction-associated steatotic liver disease.